2024-11-17 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Report

**1. Performance Comparison and Divergence:**

Teladoc Health (TDOC) has significantly underperformed the S&P 500 (VOO) over the period analyzed.  The cumulative return for TDOC is -68.16%, while the S&P 500 shows a cumulative return of 122.43%. This represents a substantial divergence of **-190.59%**. The relative divergence of 0.51 indicates that TDOC's performance is in the lower half of its historical range relative to the S&P 500.

**Company Overview:** Teladoc Health Inc. provides telehealth services, connecting patients with doctors virtually.


**Alpha and Beta Analysis:** The provided data shows high beta values (generally above 1), indicating high volatility relative to the market.  Alpha values fluctuate, showing periods of outperformance and underperformance against the market.  The recent years, particularly 2020-2024, show significant negative CAGR and substantial maximum drawdowns (MDD), indicating considerable risk.  Market capitalization (Cap(B)) has also fluctuated considerably.

**2. Recent Price Movement:**

* **Last Closing Price:** $9.21
* **5-Day Moving Average:** $9.45
* **20-Day Moving Average:** $9.14
* **60-Day Moving Average:** $8.63

The stock price is currently below its 5-day and 20-day moving averages, suggesting a potential downward trend in the short term. However, it is above its 60-day moving average, indicating some longer-term support.  The difference between the last market close ($9.19) and the closing price ($9.21) is minimal and doesn't indicate a significant price jump or drop.

**3. Technical Indicators and Expected Return:**

* **RSI (Relative Strength Index):** 50.42 –  Suggests the stock is neither overbought nor oversold, currently in a neutral territory.
* **PPO (Price Oscillator):** -0.21 – Indicates bearish momentum.
* **20-Day Relative Divergence Change:** +0.16 – Shows a short-term upward trend in relative performance compared to the S&P 500.
* **Expected Return:** 0.0% – The provided expected return of 0% suggests that no significant outperformance is anticipated over the long term (2+ years) relative to the S&P 500, at least according to the model used to generate this prediction. This is consistent with its recent underperformance.

**4. Recent Financials and Outlook:**

The provided financial data shows consistent negative EPS over the past few quarters. Revenue remains relatively stable around $0.64 - $0.66 Billion, but profitability is a significant concern. Further analysis of the earnings reports and associated press releases is needed to understand the reasons behind the losses.  The provided data lacks sufficient context to determine whether the recent earnings were in line with or better than expectations.  Comparing the reported numbers against analyst forecasts is crucial for a full assessment.

**6. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has remained relatively stable, but profit margins have fluctuated slightly.  The fact that revenue is not translating into higher profits needs investigation.

* **Capital and Profitability:**  Negative Return on Equity (ROE) in recent quarters highlights significant concerns regarding the company's profitability and efficient use of capital.  This requires further investigation to determine the underlying causes.


**7. News and Recent Issues:**

*(This section requires real-time data.  Please provide links to recent news articles or specify sources like Shacknews or Finbold for a more complete analysis.  I cannot access real-time information.)*

To complete this section, please provide links to relevant news sources covering recent earnings announcements, analyst opinions, and market outlook for TDOC.  This will allow for a comprehensive analysis of recent events impacting the stock price.


**8. Overall Analysis:**

TDOC has severely underperformed the S&P 500 over the given period.  Negative EPS, negative ROE, and fluctuating profitability raise significant concerns. Technical indicators show a neutral RSI but bearish PPO, suggesting a mixed outlook in the short term.  The long-term outlook (2+ years) appears uncertain, with a predicted 0% outperformance against the S&P 500. A thorough investigation into the underlying reasons for the company's struggles and a comparison of actual results to analyst expectations are crucial before any investment decision.  The high beta suggests significant volatility, further highlighting the inherent risk.

**9. Recommendations:**

Based on the provided data, TDOC presents a high-risk investment.  The consistent losses and negative ROE indicate fundamental issues requiring resolution.  While the short-term trend is mixed, the long-term outlook is unclear and pessimistic according to the given model.  Before considering investment, it is essential to conduct extensive due diligence, including reviewing the company's latest earnings reports, comparing actual results to analyst expectations, and thoroughly researching recent news and events. Only then can an informed decision be made, considering the significant risks involved.  Diversification within a broader portfolio is strongly advised if considering investment in this volatile stock.
